STRATA Skin Sciences (SSKN) EBITDA Margin (2012 - 2025)
STRATA Skin Sciences recorded quarterly EBITDA Margin of 41.71% in Q4 2025, up 346.4% quarter-over-quarter from 16.93% in Q3 2025, and up 8646.0% year-over-year from 0.48% in Q4 2024.
STRATA Skin Sciences' EBITDA Margin history runs 14 years deep, the most recent figure standing at 41.71% for Q4 2025.
- In Q4 2025, EBITDA Margin rose 8646.0% year-over-year to 41.71%; the TTM figure through Dec 2025 stood at 4.27% (up 2330.0% YoY), while the FY2025 annual figure was 4.27%, up 2330.0% from the prior year.
- EBITDA Margin came in at 41.71% for Q4 2025 at STRATA Skin Sciences, up from 16.93% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 41.71% in Q4 2025 to a low of 44.75% in Q4 2024.
- A 5-year average of 18.56% and a median of 18.43% in 2022 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin sank 4087 bps in 2023 and soared 8646 bps in 2025, its largest moves.
- STRATA Skin Sciences' EBITDA Margin stood at 6.87% in 2021, then surged by 118 bps to 1.26% in 2022, then plunged by 3233 bps to 39.6% in 2023, then slipped by 13 bps to 44.75% in 2024, then surged by 193 bps to 41.71% in 2025.
- According to Business Quant data, EBITDA Margin over the past three periods registered 41.71%, 16.93%, and 30.14% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn | 41.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.71% |
| Sep 30, 2025 | -16.93% |
| Jun 30, 2025 | -30.14% |
| Mar 31, 2025 | -25.03% |
| Dec 31, 2024 | -44.75% |
| Sep 30, 2024 | -18.24% |
| Jun 30, 2024 | -5.67% |
| Mar 31, 2024 | -42.75% |
| Dec 31, 2023 | -39.60% |
| Sep 30, 2023 | -6.95% |
| Jun 30, 2023 | -23.78% |
| Mar 31, 2023 | -34.17% |
| Dec 31, 2022 | 1.26% |
| Sep 30, 2022 | -8.35% |
| Jun 30, 2022 | -18.61% |
| Mar 31, 2022 | -32.71% |
| Dec 31, 2021 | -6.87% |
| Sep 30, 2021 | -6.03% |
| Jun 30, 2021 | -12.50% |
| Mar 31, 2021 | -41.05% |
| Dec 31, 2020 | -5.24% |
| Sep 30, 2020 | -20.68% |
| Jun 30, 2020 | -40.07% |
| Mar 31, 2020 | -14.09% |
| Dec 31, 2019 | 23.89% |
| Sep 30, 2019 | -9.75% |
| Jun 30, 2019 | -12.72% |
| Mar 31, 2019 | -16.58% |
| Dec 31, 2018 | 29.82% |
| Sep 30, 2018 | -4.79% |
| Jun 30, 2018 | -16.50% |
| Mar 31, 2018 | -25.23% |
| Dec 31, 2017 | -51.26% |
| Sep 30, 2017 | -183.36% |
| Jun 30, 2017 | 1.93% |
| Mar 31, 2017 | -8.60% |
| Dec 31, 2016 | -11.70% |
| Sep 30, 2016 | -19.44% |
| Jun 30, 2016 | 6.46% |
| Mar 31, 2016 | -28.06% |
| Dec 31, 2015 | -6.35% |
| Sep 30, 2015 | -146.41% |
| Jun 30, 2015 | -1,284.12% |
| Mar 31, 2015 | -4,483.95% |
| Dec 31, 2014 | -1,708.82% |
| Sep 30, 2014 | -1,049.54% |
| Jun 30, 2014 | 278.67% |
| Mar 31, 2014 | -4,846.72% |
| Dec 31, 2013 | -3,154.51% |
| Sep 30, 2013 | -5,762.16% |
| Jun 30, 2013 | -4,870.22% |
| Mar 31, 2013 | -4,500.62% |
| Dec 31, 2012 | -4,995.39% |
| Sep 30, 2012 | -7,764.99% |
| Jun 30, 2012 | -7,257.68% |
| Mar 31, 2012 | -51,301.41% |